CO · State regulatory reference
Colorado.
Moderate
Moderate. The Colorado Medical Board and Pharmacy Board have not visibly targeted peptide compounding, but Colorado generally follows USP guidance closely and out-of-state mail-order compounding is monitored.
Last reviewed · 2026-05-25 · verified entry
Agencies
TPC notes
Telehealth
Allowed broadly; established-relationship requirements apply for controlled substances.
Compounding
Active 503A presence; Colorado was a Cat-2 reclassification commenter in the 2023 cycle.